PARP Inhibitors #Short

Mechanism of PARP inhibitors - 20240509 SocialDNAing Yonghao YUПодробнее

Beyond DNA repair: the novel immunological potential of PARP inhibitors | RTCL.TVПодробнее

NERO trial: PARP inhibitors for chemosensitive NSCLCПодробнее

Current controversies in Small Cell Lung Cancer (SCLC)Подробнее

💊 Unlocking Synthetic Lethality: Targeting PARP Inhibition in BRCA1 and BRCA2 Mutant Cancers 🛑Подробнее

PARP inhibitors as first-line maintenance therapy in ovarian cancerПодробнее

Novel immunotherapy and small molecule inhibitor combinationsПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Current Controversies in Small Cell Lung Cancer (SCLC)Подробнее

Dr. Vokes on PARP Inhibitors for NSCLCПодробнее

Novel Therapies In Small Cell Lung Cancer (SCLC): LurbinectedinПодробнее

PARP Inhibitors in Small Cell Lung CancerПодробнее

PARP Inhibitors & Will They Improve Small Cell Lung Cancer?Подробнее

What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?Подробнее

SCLC: Therapeutic progress or mirage?Подробнее

Dr. Vokes Discusses PARP Inhibitors in Lung CancerПодробнее

The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian CancerПодробнее

PARP Inhibitors - Small Cell Lung CancerПодробнее

Role of PARP Inhibitors in Small Cell Lung CancerПодробнее